- May 13, 2022
- 1 min read

White House Releases 2022 National Drug Control Strategy

Washington, DC | April 2022

https://www.whitehouse.gov/briefing-room/statements-releases/2022/04/21/fact-sheet-white-house-releases-2022-national-drug-control-strategy-that-outlines-comprehensive-path-forward-to-address-addiction-and-the-overdose-epidemic/

Recent Posts

See All

Clear Scientific Awarded up to $15M from NIDA for Continued Development of Fentanyl Antidote.

Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced an award from the National Institute on Drug Abuse (NIDA) of the NIH, with a total potential val

Clear Scientific Awarded $12M NIDA Grant for Continued Development of Meth Antidote.

Cambridge, MA | Nov 2023 Clear Scientific, a clinical-stage biopharmaceutical company, today announced a $12M award from the National Institute on Drug Abuse of the NIH to support development of CS-1

Clear Scientific to Start Phase 1 Trial for Stimulant Antidote.

Cambridge, MA | Oct 2023 Clear Scientific Inc., a Cambridge MA based biopharmaceutical company, announced that the FDA has approved its Investigational New Drug (IND) application for CS-1103, the fir

White House Releases 2022 National Drug Control Strategy

Recent Posts

Contact Us